- Page 1 and 2:
Helge Garåsen The Trondheim Model
- Page 3 and 4:
Trondheimsmodellen Forbedring av ko
- Page 5 and 6:
Table of content Summary...........
- Page 7 and 8:
Summary Study I Background Optimal
- Page 9 and 10:
(p=0.003), and mean difference in c
- Page 11 and 12:
Studie II Bakgrunn Formålet med st
- Page 13 and 14:
Acknowledgments These studies were
- Page 15 and 16:
List of papers The thesis is based
- Page 17 and 18:
1.0 Introduction 1.1 Are older pati
- Page 19 and 20:
documented the benefits of using mu
- Page 21 and 22:
When composing an expert panel, it
- Page 23 and 24:
1.8 Are there any alternatives to g
- Page 25 and 26:
In the publication Scenario 2030 th
- Page 27 and 28:
trust between the patient and healt
- Page 29 and 30:
structured communication formulas (
- Page 31 and 32:
predicted increases in per capita h
- Page 33 and 34:
A study in Denmark has shown that a
- Page 35 and 36:
general hospital care. One of the c
- Page 37 and 38:
the municipalities of Trondheim and
- Page 39 and 40:
As the study in question dealt with
- Page 41 and 42:
quality of life and/or life expecta
- Page 43 and 44:
4.2.0 Study population Study II - I
- Page 45 and 46:
All data was collected by the autho
- Page 47 and 48:
An important task was to write disc
- Page 49 and 50:
to the community health system, and
- Page 51 and 52:
to information about the health car
- Page 53 and 54:
2004 and 2005. This solution was us
- Page 55 and 56:
100 % said they were treated with r
- Page 57 and 58:
compared between groups using covar
- Page 59 and 60:
care and need for long-term nursing
- Page 61 and 62:
6.1 Study I - the panel study 6.1.1
- Page 63 and 64:
e difficult for only one profession
- Page 65 and 66:
there were eleven cases with zero a
- Page 67 and 68:
trial. Participating departments at
- Page 69 and 70:
circumstances, successful diagnoses
- Page 71 and 72:
6.4 Costs 6.4.1. Cost assessments E
- Page 73 and 74:
workers, physiotherapists, occupati
- Page 75 and 76:
The good results shown in several s
- Page 77 and 78:
6.8 Discussion of the results 6.8.1
- Page 79 and 80:
to be increased with more than 99 %
- Page 81 and 82:
In study I all patient data was han
- Page 83 and 84:
Main conclusions study II: 1. Care
- Page 85 and 86:
12. Slaets JP, Kaufmann RH, Duivnvo
- Page 87 and 88:
40. Jakobsen G. Specialised palliat
- Page 89 and 90:
69. Ramrakha S, Giles A: Take a let
- Page 91 and 92:
98. Kvamme OJ. Samarbeid mellom leg
- Page 93 and 94:
127. Krummenauer F. Differenzenplot
- Page 95 and 96:
157. Kaplan RM. The significance of
- Page 97 and 98:
10.0. Appendices 10.1 VAS for refer
- Page 99 and 100:
10.2 VAS for discharge letters. Stu
- Page 101 and 102: 10.3 Criteria for inclusion. Study
- Page 103 and 104: 10.4 Procedures for including patie
- Page 105 and 106: Behov for følge av sykepleier / hj
- Page 107 and 108: 10.6 Consent formula. Study II SAMT
- Page 109 and 110: Recruitment 14 Dates defining the p
- Page 111 and 112: Personlig hygiene Ja Av og til Nei
- Page 113 and 114: eller andre steder der personen van
- Page 115 and 116: Ikke med i pleietyngdegrunnlaget i
- Page 117 and 118: Tjenester IPLOS Lov om sosiale tjen
- Page 119: 11.0 Original papers I-IV 119
- Page 123 and 124: BMC Health Services Research BioMed
- Page 125 and 126: BMC Health Services Research 2007,
- Page 127 and 128: BMC Health Services Research 2007,
- Page 129: BMC Health Services Research 2007,
- Page 133 and 134: BMC Public Health BioMed Central Re
- Page 135 and 136: BMC Public Health 2007, 7:68 http:/
- Page 137 and 138: BMC Public Health 2007, 7:68 http:/
- Page 139 and 140: BMC Public Health 2007, 7:68 http:/
- Page 141: BMC Public Health 2007, 7:68 http:/
- Page 145 and 146: Medisin og vitenskap Originalartikk
- Page 147: Originalartikkel MEDISIN OG VITENSK
- Page 151: Scandinavian Journal of Public Heal
- Page 155 and 156: 68. Trond Sand: THE EFFECTS OF CLIC
- Page 157 and 158: 139. Fabio Antonaci: CHRONIC PAROXY
- Page 159 and 160: 198. Nanna Kurtze: THE SIGNIFICANCE
- Page 161 and 162: 251. Aslak Steinsbekk: HOMEOPATHY I
- Page 163 and 164: 305. Elisabeth Olstad: GLUTAMATE AN